BIOVENTUS_LOGO.png
Bioventus Senior Management to Present at Upcoming Investor Conferences
May 17, 2021 08:15 ET | Bioventus, Inc.
DURHAM, N.C., May 17, 2021 (GLOBE NEWSWIRE) -- Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present at...
BIOVENTUS_LOGO.png
Bioventus Inc. Reports First Quarter Results; Updates Full Year 2021 Financial Guidance
May 12, 2021 16:05 ET | Bioventus, Inc.
DURHAM, N.C., May 12, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
BIOVENTUS_LOGO.png
Bioventus Announces First Commercial Shipment of the Bioness® Integrated Therapy System (BITS) Balance System
April 27, 2021 08:30 ET | Bioventus, Inc.
VALENCIA, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the first commercial...
BIOVENTUS_LOGO.png
Bioventus to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021
April 12, 2021 16:05 ET | Bioventus, Inc.
DURHAM, N.C., April 12, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that first quarter of...
BIOVENTUS_LOGO.png
Bioventus Acquires Bioness, Inc.
March 30, 2021 17:41 ET | Bioventus, Inc.
DURHAM, N.C., March 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc....
BIOVENTUS_LOGO.png
Bioventus Inc. Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Guidance
March 25, 2021 16:05 ET | Bioventus, Inc.
DURHAM, N.C., March 25, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today reported financial results for...
BIOVENTUS_LOGO.png
Bioventus Reports First Patients Enrolled in Phase 1 Clinical Trial of MOTYS™ (PTP-001) for the Treatment of Knee OA
March 11, 2021 09:00 ET | Bioventus, Inc.
DURHAM, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in solutions for innovative healing, reported that the first patients have been...
Larry Chen Joins Bioventus as Managing Director, China and Asia Pacific
March 04, 2021 09:00 ET | Bioventus, Inc.
DURHAM, N.C., March 04, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has appointed Larry Chen as Managing...
BIOVENTUS_LOGO.png
Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021
March 01, 2021 16:05 ET | Bioventus, Inc.
DURHAM, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that fourth quarter...
BIOVENTUS_LOGO.png
Bioventus Announces Pricing of Initial Public Offering
February 10, 2021 23:09 ET | Bioventus, Inc.
DURHAM, N.C., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. ("Bioventus" or the “Company”) today announced the pricing of its initial public offering of 8,000,000 shares of Class A common stock...